
HLN
Healthcare · Drug Manufacturers - Specialty & Generic · $40.25B market cap
$9.17+0.08 (+0.9%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | Before the open | — | — | — |
| Apr 29, 2026 | Time not confirmed | 0.12 | 0.00 | -100.0% |
| Oct 30, 2025 | Time not confirmed | 0.13 | 0.12 | -2.6% |
| Jul 31, 2025 | Before the open | 0.11 | 0.09 | -15.6% |
| Apr 30, 2025 | Time not confirmed | — | 0.13 | — |
| Mar 20, 2025 | Time not confirmed | 0.10 | 0.03 | -71.0% |
| Oct 31, 2024 | Before the open | 0.11 | 0.12 | +9.1% |
| Aug 1, 2024 | Before the open | 0.09 | 0.10 | +11.1% |
| May 1, 2024 | Before the open | 8.81 | 10.34 | +17.4% |
| Feb 29, 2024 | Before the open | 0.13 | 0.10 | -23.1% |
| Nov 2, 2023 | Before the open | 0.12 | 0.11 | -8.3% |
| Aug 2, 2023 | Before the open | 0.10 | 0.11 | +10.0% |
| May 3, 2023 | Before the open | 0.13 | 0.11 | -15.4% |
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins,…
| Mar 2, 2023 | Time not confirmed | 0.11 | 0.11 | +3.6% |
| Nov 10, 2022 | Time not confirmed | 0.11 | 0.09 | -20.2% |
| Sep 20, 2022 | Time not confirmed | 0.08 | 0.05 | -40.9% |
| Jun 1, 2022 | Time not confirmed | — | 0.00 | — |